OraSure Technologies Conference Call Invitation
04 July 2012 - 6:21AM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that it
will hold a conference call covering the recent U.S. Food and Drug
Administration approval of the OraQuick® In-Home HIV Test and the
Company's plans to commercialize this product, at 8:00 am ET (5:00
am PT) on Thursday, July 5, 2012. To participate in the conference
call, dial 877-348-9357 (Domestic) or 970-315-0488 (International)
and reference Conference ID #98134091.
The conference call will also be webcast live and may be
accessed on the Investor Relations page of OraSure's website,
www.orasure.com. Please click on the webcast link and follow
the prompts for registration and access 10 minutes prior to the
call.
If you are unable to participate, a replay of the call will be
archived on OraSure's website shortly after the call has ended and
will be available for seven days. A replay of the call can also be
accessed until midnight, July 12, 2012 by dialing 855-859-2056
(Domestic) or 404-537-3406 (International) and entering the
Conference ID #98134091.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: Judy Clarke
OraSure Technologies, Inc.
610-882-1820
investorinfo@orasure.com
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024
